Nalmefene Efficacy Study I: Randomised, double-blind, placebo-controlled, parallel-group, efficacy study of 20 mg nalmefene, as needed use, in patients with alcohol dependence
- Registry ID
- EUCTR2007-002334-11
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- H. Lundbeck A/S
- Start date
- 2009-03-13
- Completion date
- 2010-10-14
- Last update
- 2026-08-16
Conditions
Summary
To evaluate the effect of as needed use of 20 mg nalmefene on alcohol consumption by the monthly number of heavy drinking days and the monthly total consumption in patients with alcohol dependence during a treatment period of 24 weeks
Locations
- , , Finland
- , , Germany
- , , Sweden
- , , Austria
View on source registry